Elsevier

Journal of Hepatology

Volume 34, Issue 1, January 2001, Pages 156-160
Journal of Hepatology

Editorial
Dendritic cells: regulators of hepatic immunity or tolerance?

https://doi.org/10.1016/S0168-8278(00)00020-9Get rights and content

Introduction

The liver has a uniquely specialised immune system. On one hand it is capable of responding to danger, having multiple populations of effector lymphocytes that can effectively recognise and eliminate a diversity of pathogenic microorganisms, toxins and tumours [1]. At the same time, liver defence mechanisms are so tightly regulated that the induction of tolerance is favoured over the induction of immunity. Administration of antigens via the portal vein is more likely to lead to anergy or tolerance than systemic administration of antigen and allogeneic liver transplantation across incompatible major histocompatibility complex (MHC) barriers is often successful without the need for immunosuppression [2], [3]. Thus, local immune responses are actively regulated in the liver, presumably to maintain immune tolerance to harmless self, dietary, and commensal organism antigens that arrive from the circulation via the hepatic artery and from the gastrointestinal tract via the portal vein. The mechanisms responsible for maintaining the fine balance between immune responsiveness and non-responsiveness in the liver are largely unknown but are likely to depend on the nature of the antigen, the responding cell, and the presence of cytokines and accessory molecules in the microenvironment. A key component of this orchestration is the way in which an antigen is presented to the responding lymphocyte and recent evidence suggests that the liver has a unique repertoire of antigen presenting cells (APC). In this issue of the Journal of Hepatology, Abe and colleagues [4] investigate the potential tolerogenic or immunogenic roles of murine hepatic dendritic cells (DC) and provide experimental evidence that, in contrast to other APC populations in the liver, which can induce immune tolerance, DCs are potent immunogenic APCs. These findings are of interest in the light of other studies that have shown a tolerogenic role for hepatic DCs, and have important implications for the development of strategies for manipulating the balance between immunity and tolerance such as in the prevention of infectious and immune-mediated diseases of the liver, hepatic malignancy, and allograft rejection.

Section snippets

Antigen presentation to T cells

APCs capture, process, and display antigens to T lymphocytes leading either to their differentiation into effector cells capable of cytotoxicity and/or cytokine secretion, or to their inactivation by apoptosis or anergy [5], [6]. While B lymphocytes can directly recognise native antigens through their B cell receptors, T cells need the antigen to be processed and presented to them by the APC. Most T cells recognise peptide fragments of protein antigens presented in the groove of APC-bound MHC

Antigen presentation in the liver

The liver contains multiple types of APC. Liver sinusoidal endothelial cells (LSEC) line the liver sinusoids separating the parenchymal hepatocytes from the blood and thus sequester the liver matrix from the immune system [9]. Kupffer cells (KC) are the resident macrophage population of the liver which patrol the sinusoids and rapidly phagocytose and eliminate particulate antigens and pathogens entering the liver in portal venous blood [9]. DCs reside around the portal tracts and central veins

Induction of tolerance by hepatic antigen presenting cells

Recent evidence suggests that LSECs, KCs and DCs, can differentially mediate T cell activation or inactivation. LSECs and KCs can present portal venous antigens to CD4+ T cells without the need for further maturation, but while they induce T cell proliferation and cytokine production in vitro, they fail to induce differentiation to Th1 cells [17]. Consequently they do not promote hepatic inflammation in vivo. Instead, these APCs produce IL-10, prostanoids and transforming growth factor-β in

Hepatic dendritic cell precursors as immunogenic antigen-presenting cells

The experiments of Abe et al. [4] address the phenotypic and functional maturity of murine hepatic DCs and their role in the initiation of alloreactive and antigen-specific T cell responses. After culturing non-parenchymal cells isolated from the liver with granulocyte-macrophage colony stimulating factor, a method known to promote the differentiation of monocytes into DCs, they obtained immature myeloid DCs expressing low levels of MHC class II and CD86 and demonstrating high endocytic

Hepatic dendritic cell progenitors as tolerogenic antigen presenting cells

While the above-described experiments demonstrate that mature DCs can function as immunogenic APCs in the liver, a recent study by Khanna and colleagues [23] has shown that hepatic DC progenitors may be tolerogenic APCs. Similar to the results of Abe et al. [4], these investigators found that murine liver DC progenitors induced minimal proliferation, IFN-γ production, and cytotoxic responses in allogeneic T cells compared to bone marrow-derived DCs. However, liver DCs progenitors but not bone

Functional heterogeneity of hepatic dendritic cells

Two differences in the experimental strategies employed in the above-described experiments reveal important clues to how hepatic DC progenitors may selectively induce T cell responsiveness (immunity) or non-responsiveness (tolerance). Firstly, for the in vitro detection of the cytokines produced upon T cell activation by hepatic DC progenitors, Khanna et al. [23] used alloreactive spleen cells from MHC-dissimilar mice, while Abe et al. [4] used memory T cells taken from antigen-injected

Dendritic cells and disease

The above-described observations indicate that the three different APC types in the murine liver can selectively induce T cell immunity or tolerance, thus ensuring that the hepatic immune system can efficiently activate the immune system against pathogens and tumours whilst remaining tolerant of harmless dietary and commensal organ antigens. This heterogeneity of APC populations reflects the unique repertoire of lymphocytes found in the liver that recognise a diversity of antigen types and

Acknowledgements

This work was supported by a grant from the Irish National Liver Transplant Centre. Thanks to Dr John E. Hegarty for helpful discussions.

References (30)

  • J. Banchereau et al.

    Dendritic cells and the control of immunity

    Nature

    (1998)
  • A.K. Abbas et al.

    Functional diversity of helper T lymphocytes

    Nature

    (1996)
  • R. Ahmed et al.

    Immunological memory and protective immunity: understanding their relation

    Science

    (1996)
  • P.A. Knolle et al.

    Local control of the immune response in the liver

    Immunol Rev

    (2000)
  • J. Woo et al.

    Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells

    Transplantation

    (1994)
  • Cited by (22)

    • Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance

      2008, Blood
      Citation Excerpt :

      Natural killer (NK) and NKT cells rich in the liver can secrete chemokines to trap the activated T cells to undergo cell death in liver,5-7 which was proposed as one reason for liver tolerance. Another explanation was that some DCs in the liver secrete IL-10, which in turn induces tolerance.7-9 However, considering that such cells exist all over the body, we wonder why and how they can preferentially induce tolerance in the liver.

    View all citing articles on Scopus
    View full text